Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients

Alessandro Rossini, Roberto Lanzi, Marco Losa, Marcella Sirtori, Elisa Gatti, Sara Madaschi, Chiara Molinari, Isabella Villa, Marina Scavini, Alessandro Rubinacci

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Growth hormone (GH) replacement in adulthood results in variable bone responses as a function of the gonadic hormonal milieu. We performed a retrospective analysis of a large cohort of adult males and females with confirmed GH deficiency (GHD) prior to treatment and during 3 years of replacement therapy. Potential confounders and effect modifiers were taken into account. Sixty-four adult patients with GHD (20 females and 44 males; mean age 34 years, range 18-64) were included in the analysis. GH replacement induced a different effect on bone in males compared to females. Bone mineral content increased in males and decreased in females at the lumbar spine, total femur, and femoral neck; bone mineral density showed a similar trend at the lumbar spine and femoral neck. There was no significant gender difference in bone area at any measured bone site. In both sexes we observed a similar trend for serum markers of bone remodeling. Sex predicted bone outcome on multivariate analysis, as did age, onset of GHD (childhood/adulthood), pretreatment bone mass, baseline body mass index (BMI), and BMI change during GH replacement. Serum IGF-I levels during treatment did not show any relationship with bone outcome at any measured site. This study confirms that bone responsiveness to GH replacement in adult GHD varies as a function of sex even after controlling for potential confounders and highlights the importance of other cofactors that may affect the interaction between GH replacement therapy and bone remodeling.

Original languageEnglish
Pages (from-to)304-313
Number of pages10
JournalCalcified Tissue International
Volume88
Issue number4
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Growth Hormone
Bone and Bones
Femur Neck
Bone Remodeling
Bone Density
Spine
Body Mass Index
Hormone Replacement Therapy
Insulin-Like Growth Factor I
Age of Onset
Therapeutics
Multivariate Analysis
Biomarkers
Serum

Keywords

  • Adult GH deficiency
  • Bone
  • GH replacement therapy

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients. / Rossini, Alessandro; Lanzi, Roberto; Losa, Marco; Sirtori, Marcella; Gatti, Elisa; Madaschi, Sara; Molinari, Chiara; Villa, Isabella; Scavini, Marina; Rubinacci, Alessandro.

In: Calcified Tissue International, Vol. 88, No. 4, 04.2011, p. 304-313.

Research output: Contribution to journalArticle

Rossini, Alessandro ; Lanzi, Roberto ; Losa, Marco ; Sirtori, Marcella ; Gatti, Elisa ; Madaschi, Sara ; Molinari, Chiara ; Villa, Isabella ; Scavini, Marina ; Rubinacci, Alessandro. / Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients. In: Calcified Tissue International. 2011 ; Vol. 88, No. 4. pp. 304-313.
@article{55b2c46183684d8fb9ddb4f239bda76a,
title = "Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients",
abstract = "Growth hormone (GH) replacement in adulthood results in variable bone responses as a function of the gonadic hormonal milieu. We performed a retrospective analysis of a large cohort of adult males and females with confirmed GH deficiency (GHD) prior to treatment and during 3 years of replacement therapy. Potential confounders and effect modifiers were taken into account. Sixty-four adult patients with GHD (20 females and 44 males; mean age 34 years, range 18-64) were included in the analysis. GH replacement induced a different effect on bone in males compared to females. Bone mineral content increased in males and decreased in females at the lumbar spine, total femur, and femoral neck; bone mineral density showed a similar trend at the lumbar spine and femoral neck. There was no significant gender difference in bone area at any measured bone site. In both sexes we observed a similar trend for serum markers of bone remodeling. Sex predicted bone outcome on multivariate analysis, as did age, onset of GHD (childhood/adulthood), pretreatment bone mass, baseline body mass index (BMI), and BMI change during GH replacement. Serum IGF-I levels during treatment did not show any relationship with bone outcome at any measured site. This study confirms that bone responsiveness to GH replacement in adult GHD varies as a function of sex even after controlling for potential confounders and highlights the importance of other cofactors that may affect the interaction between GH replacement therapy and bone remodeling.",
keywords = "Adult GH deficiency, Bone, GH replacement therapy",
author = "Alessandro Rossini and Roberto Lanzi and Marco Losa and Marcella Sirtori and Elisa Gatti and Sara Madaschi and Chiara Molinari and Isabella Villa and Marina Scavini and Alessandro Rubinacci",
year = "2011",
month = "4",
doi = "10.1007/s00223-010-9459-8",
language = "English",
volume = "88",
pages = "304--313",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients

AU - Rossini, Alessandro

AU - Lanzi, Roberto

AU - Losa, Marco

AU - Sirtori, Marcella

AU - Gatti, Elisa

AU - Madaschi, Sara

AU - Molinari, Chiara

AU - Villa, Isabella

AU - Scavini, Marina

AU - Rubinacci, Alessandro

PY - 2011/4

Y1 - 2011/4

N2 - Growth hormone (GH) replacement in adulthood results in variable bone responses as a function of the gonadic hormonal milieu. We performed a retrospective analysis of a large cohort of adult males and females with confirmed GH deficiency (GHD) prior to treatment and during 3 years of replacement therapy. Potential confounders and effect modifiers were taken into account. Sixty-four adult patients with GHD (20 females and 44 males; mean age 34 years, range 18-64) were included in the analysis. GH replacement induced a different effect on bone in males compared to females. Bone mineral content increased in males and decreased in females at the lumbar spine, total femur, and femoral neck; bone mineral density showed a similar trend at the lumbar spine and femoral neck. There was no significant gender difference in bone area at any measured bone site. In both sexes we observed a similar trend for serum markers of bone remodeling. Sex predicted bone outcome on multivariate analysis, as did age, onset of GHD (childhood/adulthood), pretreatment bone mass, baseline body mass index (BMI), and BMI change during GH replacement. Serum IGF-I levels during treatment did not show any relationship with bone outcome at any measured site. This study confirms that bone responsiveness to GH replacement in adult GHD varies as a function of sex even after controlling for potential confounders and highlights the importance of other cofactors that may affect the interaction between GH replacement therapy and bone remodeling.

AB - Growth hormone (GH) replacement in adulthood results in variable bone responses as a function of the gonadic hormonal milieu. We performed a retrospective analysis of a large cohort of adult males and females with confirmed GH deficiency (GHD) prior to treatment and during 3 years of replacement therapy. Potential confounders and effect modifiers were taken into account. Sixty-four adult patients with GHD (20 females and 44 males; mean age 34 years, range 18-64) were included in the analysis. GH replacement induced a different effect on bone in males compared to females. Bone mineral content increased in males and decreased in females at the lumbar spine, total femur, and femoral neck; bone mineral density showed a similar trend at the lumbar spine and femoral neck. There was no significant gender difference in bone area at any measured bone site. In both sexes we observed a similar trend for serum markers of bone remodeling. Sex predicted bone outcome on multivariate analysis, as did age, onset of GHD (childhood/adulthood), pretreatment bone mass, baseline body mass index (BMI), and BMI change during GH replacement. Serum IGF-I levels during treatment did not show any relationship with bone outcome at any measured site. This study confirms that bone responsiveness to GH replacement in adult GHD varies as a function of sex even after controlling for potential confounders and highlights the importance of other cofactors that may affect the interaction between GH replacement therapy and bone remodeling.

KW - Adult GH deficiency

KW - Bone

KW - GH replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=79954418834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954418834&partnerID=8YFLogxK

U2 - 10.1007/s00223-010-9459-8

DO - 10.1007/s00223-010-9459-8

M3 - Article

C2 - 21253713

AN - SCOPUS:79954418834

VL - 88

SP - 304

EP - 313

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 4

ER -